Trial intelligence / Profile preview

Timing of Influenza Vaccination in Cancer Patients on Chemotherapy

NCT02213432Terminated

Sponsor
Seoul National University Hospital
Start
Sep 2014
Primary completion
Feb 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Seroprotection rate. Started Sep 2014; status: terminated.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02213432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02213432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call